Columns

Miracles of Saint Judah

  • September 1998
  • By Stephen S. Hall

When it comes to reporting on cancer "breakthroughs," journalists fall back on the same old myths.

   

One of the more amusing aspects of the recent flurry of stories about two promising new cancer treatments is the way researcher Judah Folkman, the son of a rabbi, has been hailed as a secular saint-even though all his miracles, as he's the first to admit, have taken place in mice.

Hardly a week had passed after the now-notorious May 3 front-page story in The New York Times, which described the work of Folkman's lab at Children's Hospital in Boston on endostatin and angiostatin, before Folkman was canonized. As the noted molecular biologist Yogi Berra once observed, "It's dj vu all over again."

 

To read the entire article you must log in:

Most of our content — all daily news, blogs, and videos — is free. Magazine stories are paid. To read this story, you must have a subscription or you must use a reading credit. Registration to Technology Review is free and entitles registrants to three free reading credits.

Username or REGISTER
Password  
   
 
Advertisement

MAGAZINE

Can We Build Tomorrow's Breakthroughs?

Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.

Videos

Meet 2011 TR35 Winner Jesse Robbins

More

Advertisement

Technology Review Lists

TR50

Our list of the 50 most innovative companies, including the following:

American Superconductor

BIND Biosciences

Complete Genomics

Novartis

More

Advertisement

Facebook

Advertisement